- SID Score
- 6.0/10
- Fair value
- $114.75
- Generated
- Sep 17, 2026
- Model
- claude-haiku-4-5-20251001
Oracle Corporation trades at $149.27 with a market capitalization of $561 billion, presenting a complex investment picture with divergent valuations and outlooks. The company's P/E ratio of 36.6x significantly exceeds typical technology averages, while analysts maintain a "Buy" consensus with an average price target of $319.08, suggesting 114% upside potential. However, the fair value estimate of $114.75 implies 23.6% downside, creating substantial valuation uncertainty that demands careful consideration from prospective investors.
Oracle's profitability metrics receive a C-grade, indicating adequate but not exceptional operational performance relative to peers, while the company receives failing grades in both Value (F) and Growth (F) categories. Recent earnings show mixed signals, with EPS of $1.92 on September 10 exceeding estimates of $1.67 by 15%, though subsequent earnings dates lack reported actual results. The extremely low dividend yield of 0.01% suggests Oracle prioritizes reinvestment and share buybacks over income distribution, and the absence of current annual financial data limits deeper fundamental assessment.
The stock is currently trading below its 200-day moving average of $159.45, indicating a bearish intermediate-term trend, while the 50-day moving average of $140.73 shows the stock recovering from oversold conditions. The RSI(14) reading of 45.2 suggests the stock is approaching neutral territory but not yet firmly oversold, leaving room for continued consolidation or downside pressure. The technical setup indicates a stock in transition rather than exhibiting strong directional momentum, with price discovery still ongoing between support and resistance levels.
Analyst & Insider Sentiment
Insider activity reveals mixed signals, with Levey Stuart's substantial purchase of 160,365 shares on July 24 suggesting management confidence in future prospects, yet offset by Jeffrey Henley's sales totaling 15,129 shares in late June. The significant discrepancy between analyst consensus ("Buy" with $319.08 average target) and quantitative fair value estimates ($114.75) indicates disagreement within the investment community regarding Oracle's intrinsic worth. This 58% valuation gap between analyst targets and fair value estimates raises questions about either analyst optimism or potential fundamental deterioration not yet fully priced into forecasts.
The primary risk is severe valuation overextension, with the current price 30% above the fair value estimate and trading at a 36.6x P/E ratio that leaves limited margin of safety for investors. The company's failing grades in Value and Growth categories suggest limited catalysts for fundamental appreciation, while the D-grade in Momentum indicates weakening price action that could accelerate downside moves. Additionally, the absence of recent financial data and mixed earnings results create information uncertainty, and any disappointment against the lofty $319 analyst consensus could trigger rapid multiple compression.
Oracle presents a "sell" case for value-conscious investors given the 23.6% downside to fair value and failing grades across Value and Growth metrics, suggesting the market is pricing in unrealistic future performance. While analyst optimism remains elevated and insider buying provides some confidence signal, the risk-reward profile strongly favors waiting for a more attractive entry point, particularly if the stock approaches the 200-day moving average near $159.45. Conservative investors should avoid the current valuation, while only aggressive growth investors willing to accept substantial downside risk should consider positions, and even then only with conviction in undisclosed AI or cloud initiatives not reflected in current data.
